Angiogenesis Inhibition in Advanced Non-Small-Cell Lung Cancer
September 26th, 2006
Angiogenesis inhibition is an increasingly attractive strategy for the treatment of patients with lung cancer. Join us on Tuesday, September 26, at 1 PM EST, for a Web-based, CME live conference as Drs. Joan Schiller and Mark Socinski review antiangiogenesis in advanced NSCLC and describe ongoing research with agents in development.